A new class of lipid mediators: cytochrome P450 arachidonate metabolites
about
Association of a CYP4A11 variant and blood pressure in black menRationally designed multitarget agents against inflammation and pain.Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.Can sesame consumption improve blood pressure? A systematic review and meta-analysis of controlled trials.CYP4A11 variant is associated with high-density lipoprotein cholesterol in women.Arachidonic acid metabolites in pathogenic yeasts.Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology.5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation.Genetic associations with hypertension: meta-analyses of six candidate genetic variants.Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic TargetOxidized fatty acids as inter-kingdom signaling molecules.11,12-epoxyeicosatrienoic acid attenuates synthesis of prostaglandin E2 in rat monocytes stimulated with lipopolysaccharide.Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties.Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension.
P2860
Q28274987-9DECA8C6-A20D-408B-87B3-A7F8E2AE0491Q33960685-D568600D-A008-4F60-8C79-F624126B13B8Q34313405-30B32EA3-2095-489D-B6DE-0F8374A6DB96Q34554933-F41142D2-15D4-4E96-B282-508B7B39494AQ36049377-1646C2B2-8B72-4BD3-801E-EC2B5BF4E7B9Q36329171-8481EC89-BDB3-44A8-8B03-C39CE9EF22DEQ36943169-BD0B0066-C2C0-4BBC-BA25-F7A68097DFF9Q37085844-E6EA7AE1-59B5-44FA-83C4-11B06F41E447Q37190345-FDCE3186-E88F-4CF1-9B06-9ADB190E0DC9Q37731230-7AC085A5-AABA-4EE6-B47B-86A3DAC77C2FQ38180557-FCFC2EEB-E150-44D2-94E8-8BAA831248CAQ40553922-3F46FB36-A598-40DD-B8A0-CE739AF119A2Q41833401-5E78F6D1-4886-473B-8DE9-38A08CCA6EC3Q41982469-FDCC540D-9E67-4C08-8A07-D66A3D0F0179Q42255159-7D08DC9A-AC44-4598-A1FF-B3E0E36C6D48Q44280897-D4C7AD20-283D-4C76-B0EB-7AD3B6036213
P2860
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@ast
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@en
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@nl
type
label
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@ast
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@en
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@nl
prefLabel
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@ast
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@en
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@nl
P2860
P1433
P1476
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
@en
P2093
J C McGiff
M A Carroll
P2860
P356
10.1136/THORAX.55.SUPPL_2.S13
P407
P478
55 Suppl 2
P577
2000-10-01T00:00:00Z